Background: This randomized controlled trial examines the relative efficacy of a disorder-specific treatment program (TrennungsAngstprogramm Für Familien [TAFF]; English: Separation Anxiety Family Therapy) for children suffering from separation anxiety disorder (SAD) in comparison with a general anxiety program. Method: Sixty-four children aged 8 -13 with SAD and their parents were assigned either to a 16-session disorder-specific SAD treatment program, including parent training and classical cognitive-behavioral therapy (CBT) components (TAFF), or to a general child-focused 16-week comparison group (Coping Cat [CC]) without any parent training. Diagnoses and parent cognitions were assessed at baseline and at follow-ups. Global success ratings were collected at end of treatment and at follow-up. Ratings for anxiety, impairment/distress, and life quality were collected at Baseline 1, again after a 4-week waiting period, repeatedly throughout treatment, at 4 weeks, and at 1-year follow-up. Results: The response rate (no SAD diagnosis) at 4-week follow-up among the 52 treatment completers was 87.5% vs. 82.1% (TAFF vs. CC; intent-to-treat: 67.7% vs. 69.7%). At 1-year follow-up, the response was 83.3% versus 75% (TAFF vs. CC; intent to treat: 64.5% vs. 63.6%). Differences were nonsignificant. Results from rating scales indicated improvement for both groups across time points and assessment areas, with few between-group differences, and some small effects favoring the TAFF program. Both treatment programs yielded a reduction in parental dysfunctional beliefs. Conclusions: Results indicate a slight advantage of the TAFF program over a general child-based treatment for SAD. However, these differences were less strong than hypothesized, indicating that the inclusion of parent training does not add large effects to classical child-based CBT in school-age children with SAD.
lish: Separation Anxiety Family Therapy) program incorporates disorder-specific materials that are appropriate for both adolescents as well as children as young as age 5 and includes parent training (targeting parental dysfunctional cognition, parenting behavior, and parent-child interaction), based on the embedded nature of separation anxiety within the context of the family. Unlike other anxiety disorders, which may not require parent training in treatment (Nauta, Scholing, Emmelkamp, & Minderaa, 2003) , separation anxiety directly involves and centers on primary caregivers, as children with SAD are afraid to be apart from them. Etiological research indicates that parent behaviors and cognitions are associated with the maintenance of SAD (Herren, In-Albon, & Schneider, 2013) and that parents' own psychopathology is related to child SAD (Poulton, Milne, Craske, & Menzies, 2001) . TAFF was successful in the first trial comparing treatment with a waitlist condition in young children ages 5-7 years old (Schneider et al., 2011) , with a remittance rate of 76.2% and effect sizes (d ϭ 0.98 -1.41) larger than those generally found in disorder-general treatments for anxiety disorders (In-Albon & Schneider, 2007; Walkup et al., 2008) . The present study is the first randomized controlled trial comparing family-based, disorder-specific TAFF with a disorder-general program with no specific parent training (Coping Cat [CC] ; Kendall, 1994) , using a multi-informant and multiple time point approach, with more pronounced positive effects expected for TAFF.
Method Study Design
The present study was reviewed and approved by the Basel ethics committee for medical research and conducted at the outpatient psychotherapy clinic in the Department of Psychology at the University of Basel from December 2004 to January 2009. Before treatment started, participants waited for a 4-week baseline period with one assessment before and after the baseline period in order to rule out time effects. Therapy was conducted by one fully qualified supervising psychotherapist and nine advanced clinical psychologists with specialized training in CBT. All therapists conducted treatments in both conditions. The family-based, disorder-specific TAFF treatment was administered in 16 50-min sessions, consistent with the protocol used in past research with younger children (Schneider et al., 2011) . The first 4 weeks of treatment consisted of four weekly sessions with the child and four weekly sessions with the parents, which included psychoeducation about anxiety, reframing irrational beliefs, coping strategies, and the rationale for exposure. The second 8 weeks of treatment consisted of eight weekly family sessions, divided into a parentchild part and parent-only part. During the family sessions, exposure in vivo was planned and practiced (with the therapist present, when necessary), with the last session dedicated to relapse prevention. The parent-only portions of the family sessions primarily involved discussing and practicing parental behavior during exposure of the child to separation situations.
The comparison condition consisted of 16 50-min sessions of child-focused therapy plus one wrap-up session with the parents using the CC program (Kendall, 1994) . No family received more than 16 sessions of treatment. The two treatments differed in the following ways: (a) CC treated the child exclusively, whereas TAFF treated the child and parent in equal time doses; (b) the manual and worksheets in the CC condition were designed for multiple anxiety disorders, whereas the TAFF manual and worksheets were disorder specific; (c) in contrast to CC, the TAFF condition targeted change in dysfunctional beliefs not only of the child but also of the parents; (d) in contrast to CC, in the TAFF condition parents were coached in practicing exposure with the child; (e) in contrast to TAFF, the CC condition included training and practice in relaxation techniques. Diagnostic interviews were conducted at baseline and at each follow-up (4 weeks and 12 months). Global success ratings were administered at Session 16 and each follow-up. The tertiary outcome questionnaire was administered at Baseline 1 and the 4-week and 1-year followups. All other self-report measures were administered at baseline assessments, at Sessions 4, 8, 10, 12, and 16 (end of treatment) , and at the 4-week and 1-year follow-ups.
Participants
Participants were recruited through local service providers and newspapers. Inclusion criteria were meeting full diagnostic criteria for SAD according to the Diagnostic and Statistical Manual for Mental Disorders, text revision (DSM-IV-TR; American Psychiatric Association, 2000) , age between 8 and 13 years old, German speaking, not taking medication, and written parental informed consent and verbal child assent to randomized condition assignment and completion of psychological assessments. Families received free diagnostic assessment and treatment for their participation in the study. Figure 1 provides a participation flowchart, according to CONSORT guidelines . Sixty-four children (16 boys, 17 girls in CC; 15 boys, 16 girls in TAFF) met criteria based on clinical interview and were randomized to treatment group by a statistician using a computerized permuted block design (Kracht, 1992) , with assignments concealed until the time of participation. Children, who still fulfilled inclusion criteria after the second baseline assessment, were offered treatment. In the TAFF condition, 24 out of 31 and in the CC condition 28 out of 33 participants underwent treatment. No known adverse events related to the treatment or study contributed to study withdrawal. Analyses include all available data on all children randomized to the study, and are considered intention-to-treat analyses, although posttreatment data were not available for all randomized children. Child mean age was 10.36 years (SD ϭ 1.55). No significant differences between conditions were found for gender, child or parental age, family structure, or family income. Nineteen (61.3%) children in the TAFF group and 16 (48.5%) children in the CC condition presented with comorbid disorders (some children had multiple comorbid diagnoses). This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Primary Outcome Measures
Albon, Meyer, & Schneider, in press) includes 12 items rated from 0 (never) to 4 (always). Alpha was .74 (children), .78 (mothers), and .70 for fathers. Global success. Global Success Rating-Child, Parent, and Therapist forms (modified from the Sheehan-Marks Impairment Rating; Schneider, 2000) are single-item measures rated from 1 (very much worse) to 7 (very much improved).
Functional impairment and disability. The adapted Sheehan Disability Scale (SDS; Sheehan, 1983) includes six items rated from 0 (mild) to 3 (extreme). Alpha was .84 (children), .78 (mothers), and .74 (fathers).
Secondary Outcome Measures
General anxiety. The German Revised Children's Manifest Anxiety Scale (RCMAS; C. R. Reynolds & Richmond, 1978) child version (Boehnke, Silbereisen, Reynolds, & Richmond, 1986 ) and parent version (Pina, Silverman, Saavedra, & Weems, 2001; Schneider, Adornetto, & Blatter, 2004) includes 28 yes/no items. Alpha was .86 (children), .82 (mothers), and .82 (fathers).
Quality of life. The Inventory for the Assessment of Quality of Life in Children and Adolescents: Child and Parent versions (IQL-C/P; Mattejat et al., 2005) includes nine items rated from 1 (very good) to 5 (very bad). Alpha was .78 (children), .67 (mothers), and .54 (fathers).
Tertiary Outcome Measures
Parents' dysfunctional cognitions about the child and parenting. The Parent Beliefs Questionnaire on Anxiety in Children (Nauta, Bögels, & Siqueland, 2002; German version; Herren et al., 2013) includes 45 items rated from 0 (very false; i.e., less dysfunctional) to 10 (very true), Alpha was .85 (mothers) and .85 (fathers).
Treatment integrity.
Videos of all sessions from 10 randomly selected participants in each condition were coded for therapist adherence to the protocol by two trained research assistants, using a checklist (95 total items across sessions for TAFF, 107 items for CC) developed for this study. Intraclass correlation coefficients assessed rater consistency (two-way random-effects model with absolute agreement, average measure reliability) and were .80, (p Ͻ .01 for TAFF) and .98 (p Ͻ .001 for CC). Overall therapeutic competence (implementation of treatment manual) included one item rated for each of the 16 sessions across participants, rated from 1 (very badly) to 6 (very well). Intraclass correlation coefficients assessed rater consistency and were .77 (p Ͻ .05 for TAFF) and .94 (p Ͻ .001 for CC).
Statistical Analyses
Random-coefficient models, a type of linear mixed model (Fitzmaurice, Laird, & Ware, 2004) , were used to analyze the continuous primary and secondary variables assessed at baseline, during therapy sessions, at posttreatment, and during follow-up (i.e., SAAI, SDS, RCMAS, and IQL). Our model included a random intercept as well as a random-slope parameter when this improved model fit (based on Akaike's information criterion; Singer & Willett, 2003) . Two different statistical models were set up for each nontransformed outcome. In the first model, we tested whether the slopes of the two phases (4-week baseline phase and 16-week treatment phase) differed from each other, assuming separate linear trajectories for both phases. Estimating slope parameters was less precise for the baseline phase (two time points) than for the treatment phase (seven time points). The second model compared the treatment phase with the follow-up phase, again assuming separate linear trajectories for both phases. For the follow-up phase, three time points were available to estimate slope parameters. The second model allowed us to test (a) whether This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
temporal courses differed between TAFF and CC during the treatment phase and during the follow-up phase and (b) whether treatment-specific trajectories observed during treatment were maintained during follow-up.
Results

Pretreatment Group Differences on Continuous Measures
Two-tailed independent t tests indicated no between-group differences on any pretreatment variables (see Table 1 ). Families who dropped out of the study before or during treatment did not significantly differ from those who completed treatment on any of the baseline variables.
Treatment Integrity
TAFF therapists implemented 89.5% of 95 (SD ϭ 5.6%; range ϭ 78.7%-97.7%) and CC therapists implemented 91.7% of 107 (SD ϭ 4.9%; range ϭ 83.2%-99.0%) of the critical elements raters looked for in each session, with no difference between groups, t(18) ϭ 0.90, p ϭ .38. Overall ratings of therapist competence in adhering to the treatment manual across all sessions were good, with a TAFF mean (across raters) of 5.15 (SD ϭ .42; range ϭ 4.37-5.68) and a CC mean of 5.31 (SD ϭ .43; range ϭ 4.47-5.79), with no group difference, t(18) ϭ 0.84, p ϭ .41.
Treatment Efficacy: Primary Outcomes SAD diagnoses. At 1-month follow-up, 21 children in the TAFF group (67.7% of the original intent-to-treat sample, including all dropouts; 87.5% of completers) and 23 children in the CC condition (69.7% of intent-to-treat sample; 82.1% of completers) were definitively free from SAD diagnosis, based on available data (see Table 2 ). At the 1-year follow-up, 20 TAFF children (64.5% of intent-to-treat sample; 83.3% of completers) and 21 CC children (63.6% of intent-to-treat sample; 75.0% of completers) were free from SAD. There were no significant between-group differences at either the 4-week, 2 (1, N ϭ 52) ϭ 1.42, p ϭ .23, or 1-year follow-ups, 2 (1, N ϭ 45) ϭ 3.51, p ϭ .061. There were no known adverse events in either group.
Global success ratings. Mean global success ratings (see Table  3 ) indicated perceptions that the child's symptoms were generally improved to very much improved following treatment, with only one significant group difference when analyzed using t tests.
Separation Anxiety Avoidance Inventory (SAAI). Across treatment groups and raters, SAAI values remained stable during the baseline period and declined during the subsequent treatment phase (see Figure 2 for illustration), with significantly more negative treatment than baseline slopes for mother and father ratings (see Table 4 , first column). During treatment, slopes indicated that SAAI ratings in mothers decreased faster in the TAFF than the CC group. Follow-up slopes did not differ between TAFF and CC for any rater (see Table 4 , second and third column). Mean values at the end of treatment and at the 1-month and 1-year follow-ups did not differ between the two treatments for any rater (see Table 5 ).
Impairment and disability (SDS).
Across treatment groups, SDS ratings significantly decreased over the baseline period for children, and over the treatment phase for all raters. Yet, no significant differences between baseline and treatment slopes were found across groups for any rater (see Table 4 , first column). Treatment slopes indicated that child ratings decreased (i.e., improved) significantly faster in TAFF compared with CC (see Table  4 , second column). Follow-up slopes indicated that father ratings decreased (i.e., improved) significantly faster in TAFF compared with CC (see Table 4 , third column). Similar to SAAI ratings, mean values of SDS ratings at the end of treatment and at the 1-month and 1-year follow-ups did not differ between the two treatments for any rater (see Table 5 ). d Two of these met criteria for a different anxiety disorder diagnosis. Chi-square tests comparing TAFF and Coping Cat groups on the presence of any anxiety disorder (including SAD) indicated no significant between-group differences at either follow-up. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Treatment Efficacy: Secondary Outcomes General anxiety (RCMAS) and quality of life (IQL).
Across treatment groups, RCMAS and IQL ratings significantly decreased over the 4-week baseline period in children and fathers, and over the treatment phase for all raters. The baseline RCMAS slope was significantly more negative than the treatment slope for fathers (indicating faster decline/improvement over the baseline than the treatment period). Differences between IQL baseline and treatment slopes were not significant across groups for any rater (see Table 4 , first column). For RCMAS, neither treatment slopes nor follow-up slopes differed between treatments for any rater, indicating that RCMAS ratings changed at similar rates across groups during treatment and follow-up. For IQL, treatment slopes were significantly more negative for TAFF compared with CC in mothers and fathers, indicating that parents' RCMAS ratings declined (i.e., improved) more quickly in the TAFF group than in the CC group during treatment. Follow-up slopes did not significantly differ between treatments for any rater, indicating comparable rates of change after the end of treatment (see Table 4 , second and third column). Mean values did not significantly differ between the two treatments for any rater at any time point (see Table 5 ), with one exception: Mother IQL ratings at 1-year follow-up were significantly lower in TAFF than CC, indicating better quality of life.
Treatment Efficacy: Tertiary Outcomes
Treatment ؋ Time Effects on Parent Cognitions. Results of linear mixed models with time (baseline, 4-week follow-up, 1-year follow-up) and treatment (TAFF vs. CC) as fixed effects indicated significant time effects on parent dysfunctional cognitions in mothers, F(95.6) ϭ 30.6, p Ͻ .001, and fathers, F(70.3) ϭ 40.8, p Ͻ .001, with declines in dysfunctional cognitions from baseline (mothers M ϭ 3.29, SD ϭ .95; fathers M ϭ 3.05, SD ϭ .91) to the 4-week follow-up (mothers M ϭ 2.52, SD ϭ 1.02; fathers M ϭ 2.19, SD ϭ .84), and 1-year follow-up (mothers M ϭ 2.14, SD ϭ 1.11; fathers M ϭ 1.68, SD ϭ .82), across conditions. There were no significant group effects or Group ϫ Time interactions.
Discussion
The present study extends previous research, which indicated that disorder-specific family-based therapy (TAFF) works in This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
comparison to a waitlist in young children with SAD (Schneider et al., 2011) , by comparing the TAFF program with a wellestablished general child-based treatment for anxiety disorders (Kendall, 1994) . Advantages of the present study included use of a multi-informant assessment approach and expanded data collection over an initial baseline waiting period, and then at multiple time points throughout therapy and two follow-ups. The response rate (no SAD diagnosis) at the 4-week follow-up among 52 completers was 87.5% versus 82.1% (TAFF vs. CC); intent to treat: 67.7% vs. 69.7%. At the 1-year follow-up, the response was 83.3% versus 75% (TAFF vs. CC); intent to treat: 64.5% versus 63.6%. The two treatment groups produced statistically equivalent effects in reducing the number of SAD diagnoses. Results from the rating scales pointed to a few small effects generally favoring the TAFF treatment over CC in treating children with SAD, with statistical equivalence of the This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
two treatments on the majority of indicators. Overall effect sizes across treatments obtained in the present study for treatment slope versus baseline slope were comparable to the medium pre-, posttreatment effects obtained in other studies examining CBT for childhood anxiety disorders (In-Albon & Schneider, 2007; Walkup et al., 2008) . They were somewhat lower than the large effects found when comparing the TAFF program with a waitlist in younger children (Schneider et al., 2011) , in line with other studies showing a better outcome for younger children with anxiety disorders (Hirshfeld-Becker et al., 2010) . (It must be noted that the effect sizes in these studies do not all assess equivalent effects, as the present study compared slopes and prior studies compared pre-post effects.) Somewhat surprisingly, parental dysfunctional cognitions about their child and parenting were significantly improved and comparable in both treatment conditions, indicating that a change in parental dysfunctional cognition may not require a thorough discussion with the parents themselves as in the TAFF treatment. Overall, this study may provide some insight into the active ingredients of successful SAD treatment. The two treatment programs used in the present study shared several essential elements in common; most important, they shared an intensive and closely monitored exposure in vivo as well as psychoeducation, elements targeted at improving anxietyproducing cognitions in the child. When added to these essential components, additional TAFF components including providing disorder-specific treatment material, inclusion of the parent, and discussing dysfunctional parental beliefs and coaching the parent to practice exposure to separation situations appear to make only small improvements in outcomes. Limitations of the present study included a lack of widely acceptable methods for calculating effect sizes in the present analyses (mixed models) and low power to assess therapist effects on outcomes and treatment integrity. Future studies should parse out the essential ingredients for treatment success, examining the relative effects of in vivo exposure, parent involvement, disorder specificity, and the like, using an experimental design, a larger sample, and increased power. Future studies should also investigate specific subgroups of SAD that may profit more from a family-based treatment. In sum, TAFF may be a viable option when parents are available and wish to be involved in treatment. However, when efficiency and minimal parental time involvement are desirable or necessary, therapists and parents may trust that both child-based and family-based treatment for SAD produce positive results.
